Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: apatinib+oral etoposide
Sponsor: Chinese Academy of Medical Sciences